drugset / Trial / NCT03958344

Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation

NCT03958344

RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter randomised double-arm clinical trial, to compare safety and efficacy of oral versus intralesional injection of steroid in a group of patients suffering from idiopathic orbital inflammation is designed. Outcome measures include number of recurrences, duration of remission, and side effects.

Timeline

Start
2022-01-01
Primary completion
2024-06-01
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 6 mg Other
Comparator Prednisolone Other / unclassified 1 mg/kg Oral
Subject Triamcinolone Other / unclassified 40 mg Other

Indications